InvestorsHub Logo
icon url

CaptBeer

08/02/24 4:14 PM

#427659 RE: Whalatane #427658

Thanks for the info. However, after the heartbreak from this, I’ve promised myself to not take any more positions in biotechnology. After I see this one conclude I’ll move on to areas I know better such as energy and minerals, and pure technology.
icon url

Birdbrain Ideas

08/02/24 4:40 PM

#427660 RE: Whalatane #427658

As long as we're sharing alternatives to AMRN for fellow beleaguered shareholders who like to get behind a company they think could do good against debilitating diseases, I've bought a bunch of ATOS, which is supposed to release findings within months of trials of a drug that is aimed at dramatically reducing the damage done by breast cancer and ANVS, which is one of the companies positioning itself to be a player in the Alzheimer's treatment space. What I like about ANVS is that its share float is only about 8 million and it's valued at less than $100 million. It's selling for half of what it was worth three weeks ago. As for ATOS, the company's owner has said he wants to position the company for a sale if the trial results in the next six months live up to expectations.
icon url

Jasbg

08/02/24 5:35 PM

#427662 RE: Whalatane #427658

Whala, Again - again - again - 20800 plus ways in undermining trust in Amarin and Vascepa.
-----------------------------

Seriously - Other Bio's !!!

People on this board (unlike you) are many of them (us) invested BIG in Amarin - so please take your Pumping other Bio's to other boards !!!
icon url

DAR53

08/02/24 6:47 PM

#427672 RE: Whalatane #427658

Whal, you may be right but over the past 6 months the stocks you mention have dropped as shown below.
ARDX down 50%
UNCY down 76%
FULC down 21%
For now I'll stick with the devil I know.